Dube Michael P Insider Trades

Insider Trading History

Track insider trading activity for Dube Michael P. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Intellia Therapeutics
Intellia Therapeutics NTLA
Vp, Chief Accounting Officer
Holding Value $1.03M 69,527 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$238k 17,250 shares
$13.78
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Vp, Chief Accounting Officer
Holding Value $771k 52,277 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$27.5k 2,989 shares
$9.21
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Vp, Chief Accounting Officer
Holding Value $815k 55,266 shares
Last Trade
Oct 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$32.5k 1,871 shares
$17.38
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Vp, Chief Accounting Officer
Holding Value $843k 57,137 shares
Last Trade
Jul 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$24.9k 2,503 shares
$9.95
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Vp, Chief Accounting Officer
Holding Value $880k 59,640 shares
Last Trade
Mar 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$141k 14,000 shares
$10.09
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Vp, Chief Accounting Officer
Holding Value $673k 45,640 shares
Last Trade
Jan 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.7k 1,372 shares
$12.18
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Vp, Chief Accounting Officer
Holding Value $693k 47,012 shares
Last Trade
Oct 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$38.2k 2,012 shares
$19.01
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Vp, PAO And Interim PFO
Holding Value $723k 49,024 shares
Last Trade
Jul 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 17,801 shares
$22.47
$14.75

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up